Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001699493-17-000001
Filing Date
2017-03-02
Accepted
2017-03-02 15:13:09
Documents
1
Effectiveness Date
2017-03-02
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 9894
  Complete submission text file 0001699493-17-000001.txt   10899
Mailing Address 210 BROADWAY CAMBRIDGE MA 02139
Business Address 210 BROADWAY CAMBRIDGE MA 02139 857-488-4488
Arrakis Therapeutics, Inc. (Filer) CIK: 0001699493 (see all company filings)

EIN.: 475064524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-281666 | Film No.: 17658355